Novo Nordisk’s India team played a pivotal role in the success of Ozempic, a semaglutide-based drug for diabetes and weight management. The Bengaluru-based Global Business Services unit collaborated on clinical trials and biostatistics. Despite global demand, Ozempic’s availability in India remains uncertain due to supply challenges, with significant hiring planned to bolster Novo Nordisk’s workforce in India.
Ozempic: Bengaluru is the secret ingredient behind the wonder weight loss drugs’ success
